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ABSTRACT 
Objectives  In this prospective study we aimed to determine the distribution of genotypes by multi-
locus variable number tandem repeat (VNTR) analysis plus analysis of the ompA gene (MLVA-
ompA) of rectal Chlamydia trachomatis (CT) among MSM attending Brighton GUM Clinic and to 
examine any correlations with clinical variables including HIV status, and to isolate rectal CT 
cultures maximising the possibility of obtaining complete genotyping data.  
Methods Samples were assigned genotypes by PCR and sequencing of the markers of the 
MLVA-ompA genotyping system. Rectal CT was isolated in cell culture using McCoy cells. Data 
regarding demographics, HIV status, rectal symptoms, past history of STIs including CT were 
collected.  
Results 1809 MSM attending the clinic between October 2011 and January 2013 took part in the 
study, 112 (6.2%) of whom had rectal samples which tested positive for CT. 85/112 (75.9%) CT 
positive rectal samples were assigned 66 different genotypes. Two distinct genotype sub-clusters 
were identified: Sub-cluster 1 consisted of more HIV-negative men than sub-cluster 2 (p=0.025), 
and the MLVA-ompA genotypes in these sub-clusters reflected this. Isolates were successfully 
cultured from 37 of the 112 specimens, from which 27 otherwise unobtainable (from direct PCR) 
MLVA-ompA genotypes were gained.  
Conclusions The most prevalent genotypes were G, E and D representing some overlap with the 
heterosexual distribution in UK. Sub-cluster 1 consisted of more “heterosexual genotypes” and 
significantly more HIV-negative men than sub-cluster 2, associated with “MSM genotypes”. There 
was a higher diversity of CT strains among MSM in Brighton than observed in other cities. 
INTRODUCTION 
Rectal Chlamydia trachomatis (CT) remains one of the most commonly diagnosed bacterial 
sexually transmitted infection (STI) among men who have sex with men (MSM) attending GUM 
clinics in the UK1. There is strong evidence for the role of rectal STIs as a risk factor in both the 
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acquisition and transmission of HIVW1-3 and routine rectal testing in MSM is recommended in 
national guidelines2. 
Different CT strains determine disease outcomes (for example there is linkage of 
lymphogranuloma venereum (LGV) strain L2b to proctitis in MSM3 4. The majority of infections 
occur within transmission networks5 6,  therefore knowledge of different genotypes is useful for 
mapping transmission within sexual networks and surveillance of emerging trends. In the past two 
decades, genotyping of CT has relied on PCR and sequence analysis of the ompA gene7-12.  But 
within each ompA genotype, very little variation exists with respect to ompA sequences 6 13 14. 
Furthermore, genome sequencing data reveals that ompA must not to be relied upon solely as a 
marker for genotyping, as recombination of all or parts of this gene within and between biovars is 
evident15. There are now several very highly discriminating multi-locus molecular typing systems 
including multi-locus sequence typing (MLST) for CT that allow differentiation and sub-grouping of 
isolates within a genotype13 16 17 W4-6. The multi-locus variable number tandem repeat (VNTR) 
analysis plus analysis of the ompA gene (MLVA-ompA) high resolution genotyping system of 
Pedersen et al (2008)13, has been successfully evaluated18 and recent work has shown that the 
VNTR marker sequences are stable and therefore ideal for genotyping19. The system consists of 
short, easy to amplify markers (the longest being part of the ompA gene) which are simple to 
manipulate and yield a high efficiency return of results as demonstrated in the quoted surveys . It 
also has an optimal ability to differentiate between genotypes20, as measured by the Simpson’s 
discriminatory index13 18. 
 
The diversity of CT in the heterosexual population has already been characterized and thus the 
selection of genotypes that form this population are well-established and set the baseline of known 
strains13 21 22.   Previous work has reported differences in the distribution of CT genotypes between 
heterosexual and MSM populations69 and sexual behaviour factors, social and sexual network 
movement, and tissue tropism may account for these differences. According to current literature, 
the distribution of genotypes in rectal infections among MSM is dominated by D, G and J6W7-10.  
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However, little is known with regards to the more detailed molecular analysis of the CT genotypes 
that inhabit the rectum, although a study in Amsterdam attempted to compare anorectal samples 
from MSM and women23, searching for evidence of rectal tropism.  
The purpose of our work was to evaluate whether the MLVA-ompA genotyping scheme could be 
adapted and applied to rectal specimens in a MSM population looking for correlations with clinical 
variables including HIV status.  A unique and additional aspect of our project was to isolate rectal 
CT in cell culture.  This component was included to maximise the possibility of obtaining complete 
genotyping data and to provide a fully characterisable collection of live rectal CT isolates for future 
studies into tropism in vitro.  
The aims of this study were to determine the distribution of CT genotypes found in rectal infection 
in MSM attending a GUM clinic in the UK city of Brighton, to compare this between HIV-positive 
and HIV-negative men and  to examine any clinical correlations with certain genotypes. 
 
METHODS 
Participants  
Participants were men reporting sex with other men, undergoing rectal testing for CT at the GUM 
clinic between October 2011 to January 2013. Males <16 years old were not eligible. Participants 
could be recruited more than once if the period between consecutive visits was greater than three 
months. If more than one sample was collected from the same patient in less than three months 
(e.g. on the same day), one of these was excluded from the study. 
Specimen collection and storage 
Men were only eligible for our study if they underwent proctoscopy i.e. had direct visualisation of 
the rectum and swabs taken directly from the rectal mucosa and not sweeping the perianal area 
on the way in so the provenance of our specimens as rectal was assured. In addition to the routine 
nucleic acid amplification test (NAAT) with the BD Probetec™ assay (Becton-Dickinson, Sparks, 
MD, US), clinicians took a separate rectal swab (Σ-VCM™; Sigma, Poole, UK) for cell culture of 
CT, which was stored at -80°C. If a participant was found to have rectal CT on local testing, stored 
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supplementary rectal samples were transported on dry ice to The University of Southampton 
Molecular Microbiology Group for tissue cell culture and genotyping. Stored specimens from 
patients subsequently found to be CT-negative were discarded. All patient identification 
information was removed and samples anonymised prior to transport to Southampton.  
Patient demographic and clinical data 
Data regarding demographics, HIV status and clinical parameters: rectal signs and symptoms, 
history of unprotected sex in the previous 3 months  and history of previous STIs were retrieved 
from patient case notes and recorded on a Microsoft Excel spreadsheet.   
DNA sequence analysis of MLVA-ompA markers and tissue culture of C. trachomatis 
Methodological details of DNA extractions from samples, PCR, sequence analysis and tissue 
culture isolation of C. trachomatis can be found in Web Appendix 1. 
 
Statistical methods  
Fisher’s exact test (using the statistical software package SPSS version X21) was used for 
statistical analysis of associations between CT sub-clusters and clinical parameters.  
 
Ethics 
This study was approved by Brighton East Research Ethics Committee (REC reference 
11/LO/0745).  
 
RESULTS 
 
Participants  
1809 men consented to participate in this study (the clinic tests approximately 3000 MSM for STIs 
per year), from which 112 CT-positive rectal samples were obtained (6.2% positivity for rectal CT). 
Seven of these men also had concurrent urethral CT. Complete paired MLVA-ompA genotypes 
were only obtained for three of these seven participants. These three paired results were: for 
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participant 6 rectal swab: 8.5.5-L2, urine: 8.5.1-E; for participant 50 rectal swab 3.5.3-G, urine 
3.6a.3-G; for participant 79 rectal swab 3.6.4-D, urine 3.6a.4-G. Of the four incomplete paired 
MLVA-ompA genotypes (where one or more loci were not sequenced), two included individual 
paired loci which differed between the rectal swab and urine and therefore these two samples 
could also represent different  MLVA-ompA genotypes. 
Mean age of men with rectal CT was 39 years (median 40, interquartile range 31-46), 104 (93%) 
were Caucasian and 47(42%) were HIV-positive. 
85/112 (76%) of CT-positive rectal samples were assigned full MLVA-ompA profiles. All of the 
other samples had types assigned to at least two markers based on direct patient samples.  
 
Genotypes identified among MSM in Brighton 
Amongst the 85 fully-genotyped samples there were 66 different MLVA-ompA sequence types 
(Table 1).  
Table 1 MLVA-ompA genotypes according to HIV status 
ompA  MLVA* 
HIV positive 
(number of CT 
positives) 
HIV negative 
(number of CT 
positives) 
 
D/IC-
CAL8† 3.6.4  1 
 3.8.1 1  
 6.13.3 1  
 8.5.1  3 
 8.6.4 1  
 8.6.5  1  
 8.7.2 1  
 8.8.1  1 
  8.8.3 1  
 14.7.3  1 
 
D/UW-
3/CX† 3.6.4  1 
 8.2.4 1  
 8.4.1  1 
 8.6.1  1 
 8.6.3  1 
 
E 3.7.2  1 
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 8.2.1  1 
 8.3.1 1  
 8.3.2  1 
 8.5.1 1 4 
 8.5.3 1 1 
 8.6.1  1 
 8.7.1 1 2 
 8.7.2 1  
 8.7.4 1 1 
 8.9.1 1  
 8.9.3  1 
 
F 8.2.4 1  
 8.4.5  1 
 8.5.1 2 1 
 8.7.3 1  
 8.8.2 1  
 
G 1.3.3  1 
 2.5.3 1  
 2.5.4  1 
 2.11.4  1 
 3.2.4  1 
 3.3.3 1  
 3.4.3 1 1 
 3.5.3  1 
 3.6.3  2 
 3.6.4  1 
 3.7.3 3  
 8.5.1  1 
 8.5.2 1  
 8.5.4 1  
 8.5.5  2 
 8.6.2  1 
 8.6.3 1  
 
I 8.7.5  1 
 
J 1.6.3  1 
 2.7.3  1  
 3.2.4  1 
 3.5.2 1  
 3.5.3  1 
 8.3.4 1  
 8.9.2  1 
 
L2 1.9.4 1  
 8.5.5  1 
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L2b 1.5.2 1  
 1.5.3 1  
 1.9.1 1  
 1.9.2 1 2 
 3.5.2 1  
 8.5.4  1 
 8.5.5  1 
 
*MLVA genotype is designated in order of loci: CT1335; CT1299; and CT1291 
†ompA genotype D is subdivided into D/IC-CAL8 and D/UW-3/CX 
The most prevalent ompA genotypes were G, E and D comprising 19.6%, 17.9% and 15.2% of the 
112 positive samples respectively (Table 2). There were two D subgroups: D/UW-3Cx and D/IC-
CAL8 which comprised of 4.5% and 10.7% respectively (Table S2). The distribution of ompA 
genotypes from most to least numerous was: G, E, D, L2, F/J (both same number of samples), 
and I (Table 2). Column two of Table 2 shows the total number of rectal specimens per ompA 
genotype, and column three shows the number of these which were culturable. 
 
Table 2 Distribution of MLVA-ompA genotypes among CT positive MSM in Brighton 
ompA genotype Number rectal specimens Numberrectal Number different MLVA- 
   (% of 112 CT   specimens  ompA genotypes 
   positive specimens)  culturable 
 D   17 (15.2)   7   15 
 E   20 (17.9)   6   12 
 F   7 (6.3)   3     5 
 G   22 (19.6)   9   17 
 I   1 (0.9)   0     1 
 J   7 (6.3)   4    7 
 L2   2 (1.8)   1    2 
 L2b   9 (8.0)   6    7 
Not fully genotyped  27 (24.1)   1*     - 
 Total   112 (100)   37   66 
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*One cultured isolate was successfully identified as ompA genotype G, but the CT1299 sequence 
analysis did not work on this sample, hence it is categorised as not fully MLVA-ompA genotyped. 
 
Six new VNTR repeats were identified in this study (Table 3), in addition to those described in 
Pedersen et al (2008)13 and Wang et al (2011)18. 
Table 3 New types and variants of the variable number tandem repeats (VNTRs) identified in this 
study 
VNTR type* Variant number of VNTR type and associated repeat sequence 
CT1335 14 14T7A 15 11T9A 
CT1299 10 15C  11 16C  12 18C 13 21C 
*No new variants for CT1291 were identified 
 
In most cases the MLVA types were unique to the ompA genotypes. However, eleven MLVA 
genotypes were associated with more than one ompA genotype. These MLVA types were; 3.2.4, 
3.5.2, 3.5.3, 3.6.4, 8.2.4, 8.5.1, 8.5.4, 8.5.5, 8.6.1, 8.6.3, 8.7.2 (Table S2). The MLVA-ompA profile 
most commonly detected was 8.5.1-E-Bour which was identified in five patients. MLVA type 8.5.1 
was also the MLVA type most associated with different ompA genotypes: it was identified in four 
ompA genotypes. Genotypes H and K were not detected from any of the samples 
 
Cluster Analysis of genotype distribution among MSM in Brighton 
Owing to the variation of genotypes within the highly diverse number of fully genotyped samples in 
this study (85), it proved necessary to identify possible founder groups within the minimum 
spanning tree, so as to enable statistical analysis of sub-clusters. Two possible sub-clusters were 
identified (sub-cluster 1 & sub-cluster 2, Fig. 1) on the basis that the putative sub-cluster founders 
(A & B, Fig. 1)  had five or more single locus variants (SLVs) associated with them. Only SLVs and 
double locus variants (DLVs) of the sub-cluster founders A and B were included in further analysis. 
Statistical analysis using the Fisher’s exact test showed a significant difference between the sub-
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clusters  with respect to HIV status (p=0.025). Most genotypes were from either HIV-positive or 
HIV-negative MSM (27 genotypes were from HIV-positive MSM only; 32 from HIV-negative MSM 
only). There were seven genotypes that were found in both HIV-positive and -negative MSM, 
which were ompA type E (4 genotypes); F (1 genotype); G (1 genotype); and L2b (1 genotype) 
(Table 1). Sub-cluster 1 consisted predominantly of HIV-negative men and sub-cluster 2 of HIV-
positive men (see also Fig S2). The distribution of ompA genotypes in sub-cluster 1 was mainly 
ompA D, E and F (p<0.001), whereas that in sub-cluster 2 consisted mostly of ompA G,  and J 
(p<0.001), and there were ompA D and L2b genotypes closely associated with this cluster (Fig. 1). 
There were seven different MLVA-ompA genotypes amongst the nine L2bs in this study, five of 
which were from HIV positive MSM and four were from HIV negative MSM. Of the 85 fully 
genotyped samples, 66 had unique MLVA-ompA genotypes (Tables 2 and 3).  
 
Cultured isolates 
33% (37/112)  of the samples were successfully isolated in cell culture. The distribution of ompA 
genotypes amongst these isolates was as follows; G (n=10), E (n=6), D (n=8), and L2B (n=6) 
(Table 2). MLVA-ompA genotypes 3.4.3-G, 8.5.1-F, 8.7.1-E and 1.9.2-L2b were found in multiple 
culture-positive samples. In some of these cases, (8.5.1-F; 8.7.1-E), genotypes were detected in 
direct patient samples, and post culture (but not from the same patient). Two of the samples with 
MLVA-ompA genotype 1.9.2-L2b were collected on the same day. 
 
Clinical correlations 
There were no significant clinical differences between HIV-positive and HIV-negative men. 
Overall 75% of individuals were asymptomatic with regards to rectal symptoms (including pain, 
bleeding, tenesmus, constipation, diarrhoea, discharge and perianal itch). Individuals with ompA 
genotype L2/L2b were more likely to be symptomatic (64% of individuals with this genotype were 
symptomatic) than any of the other ompA genotypes. Further analysis using Fisher’s exact test 
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showed that there was no statistical significant differences with respect to rectal symptoms 
(p=0.725) or signs (p=1.000) and MLVA-ompA genotypes between sub-clusters 1 and 2.   
 
DISCUSSION 
This is the first MLVA-ompA study of CT in MSM with HIV. Using this method we have seen much 
greater diversity in CT genotypes than was expected in comparison to other studies using other 
genotyping schemes6W10; however, there are some trends and significant findings. 
  
Our principle finding in this prospective study is that there are distinct sub-clusters of chlamydial 
genotypes for HIV positive and HIV negative MSM.  We have also observed that the distribution of 
ompA genotypes amongst MSM overall differed somewhat from that previously described6 W10-11. 
We found that the three predominant ompA genotypes were, in descending order: G, E and D, 
whereas elsewhere studies have shown predominant MSM genotypes to be G, D and J6 24 W10. 
The Brighton ompA distribution bears a close resemblance to that of MSM in Northern Spain25.  
The second most prevalent ompA genotype amongst our samples was E which is the predominant 
ompA genotype among heterosexual individuals. This overlap is further represented by MLVA-
ompA genotype 8.5.1-E, the predominant genotype in both this study and a study of Southampton 
women18. A unique finding is that this genotype could represent a bridging population between 
heterosexual females and MSM that could be responsible for the transmission of CT between risk 
groups. Alternatively, this particular genotype may have been introduced the MSM network some 
time ago and has since been circulating among predominantly HIV-men.  
Specifically, whilst there was no significant symptomatic correlation between HIV positive and HIV 
negative men there was a trend for individuals with ompA genotypes L2/L2b to be symptomatic 
compared to those with any other genotype, in keeping with what is already known of the current 
LGV epidemic in MSM26. Whilst the initial LGV outbreak was characterised by a painful proctitis 
and, on fewer occasions, an inguinal syndrome, the number of asymptomatic individuals at that 
time was low. However, the most recent national LGV case-finding exercise found that 22% of 
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LGV cases were asymptomatic, a quarter of those being pre-symptomatic i.e. men were 
asymptomatic at first visit but symptomatic by the time they attended for treatment of rectal 
chlamydia27. Despite smaller numbers, our data showed an asymptomatic LGV rate of 36%, 
slightly higher than the national rate but also consistent with the changing epidemiology of LGV. 
In terms of strengths and weaknesses, the sample size was small giving insufficient power to 
make symptomatic associations with the large diversity of genotypes. Inherent to many 
epidemiological studies in MSM, the challenges of contact tracing in MSM, who often have 
multiple and anonymous partners, makes obtaining information for complete clusters and sexual 
networks difficult. 
There is some debate over what influences the site of C. trachomatis replication, whether it is 
tissue tropism or sexual behaviour, or both. However, a recent study comparing MLST types of C. 
trachomatis from women (anorectal, cervical, vaginal, pharyngeal) did not correlate genotypes with 
these sites23. Geisler et al. (2008) examined ompA genotypes in women showing that rectal CT 
genotype distribution was similar to that of genital CT28, notably genotype E. By contrast genotype 
G, which was found commonly in the rectums of MSM, was seldom seen at either cervix or rectum 
in women. From this it would appear that sexual behaviour factors and epidemiology play a 
significant role. Another study used WGS to identify correlations between polymorphisms in 
specific loci and tissue tropism. Strong associations with rectal tropism were found for 
polymorphisms in serovar G29. 
Of the seven participants from whom we obtained paired samples, five appeared to have different 
MLVA-ompA genotypes in the rectal compared to urine samples. This suggests that these 
participants may have been in sexual contact with a wider network. 
This is a meaningful study since we have shown that the MLVA-ompA high resolution genotyping 
system can be successfully applied to rectal samples in MSM and that the recovery rate of CT in 
cell culture from rectal swabs (33%) was greater than has previously been reported. The 
implications for clinicians is that different behaviours amongst HIV positive and HIV negative MSM 
affect co-infections with chlamydial genotypes, and is encouraging evidence for serosorting 
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behaviour (a known HIV transmission reduction strategy).  Policy makers should note that paying 
attention to identification of “HIV-positive MSM C. trachomatis genotypes” can lead to trapping 
high risk networks in terms of reducing onward transmission of and avoidable deaths from HIV. 
Implications from our study also indicate that future vaccines for C. trachomatis must encompass 
all genotypes and cannot be targeted to single groups such as HIV positive MSM. 
Our second main finding is based on minimum spanning tree analysis and the derivation of two 
distinct sub-cluster, suggestive of two separate sexual networks. Sub-cluster 1 consisted of more 
“heterosexual” CT genotypes, reinforcing the suggestion that linkages between risk groups exist, 
whereas sub-cluster 2 displayed a genotype distribution more typical of that previously seen in 
MSM. However, these two sub-clusters are closely related genetically, differing by no more than 
DLVs, which indicates that there is a circulating pool of closely related strains in a single sexual 
network, which can only be subdivided into  “more MSM-like” and “more MSW-like” sub-groups. 
Furthermore, sub-cluster 2 consisted of significantly more HIV-positive men, suggesting that these 
men choose sexual partners from within risk groups, i.e. serosorting. The LGV epidemic over the 
last 10 years has largely affected HIV-positive men and, within this, a distinct group of men with 
specific behaviour patterns has been implicated. It follows that other genotypes may also be found 
in higher rates among HIV-positive individuals but the fact that they are clinically indistinct from 
other non-LGV  genotypes, being mainly asymptomatic, means that we are less likely to be aware 
of them. Indeed an alternative explanation would be that HIV-positive individuals who are immune 
suppressed are less able to clear certain types of CT.  
Further larger studies examining rectal genotypes are needed to enable sexual network mapping. 
Moreover, similar studies in women will provide useful insight into whether certain CT genotypes 
have a predilection for the rectum because of sexual behaviour factors and tissue tropism. 
One unanswered question is whether the 8.5.1-E found in MSM is similar or quite different to the 
8.5.1-E found in the cervices of women. Further work includes whole genome sequencing (WGS) 
which will facilitate comparison between 8.5.1-E isolate(s) observed in the current MSM study and 
the women’s study18. Comparison of total single nucleotide polymorphism differences (SNPs) 
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within the women’s 8.5.1-E isolates to those of MSM will reveal if there is a significant difference or 
not, and therefore support a conclusion as to whether or not the “MSM 8.5.1-E” is the same as the 
women’s “heterosexual 8.5.1-E”. Whilst not part of the present study, further work will involve 
detailed in vitro analysis of the tropism of the cultured rectal isolsates. 
In conclusion, we have been able to identify an association of MLVA-ompA genotypes with HIV 
status and our results indicate a possible network within Brighton defined by HIV status.  
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KEY MESSAGES 
 There is a wide diversity of C. trachomatis genotypes as defined by MLVA-ompA typing 
circulating in the MSM population of Brighton. 
 High-resolution multi locus VNTR analysis – ompA genotyping points to discrimination of 
sub-clusters of MSM who are distinguishable by their HIV-status. 
 Heterosexual genotypes circulate within the MSM community in Brighton, but appear to be 
more associated with HIV negative MSM. 
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Figure 1 Minimum-spanning tree of 85 MSM samples from Brighton. Each coloured circle 
represents a MLVA-ompA genotype. Segmentation within the circles shows the number of 
samples per genotype, branches show single-locus variants (SLV). Unlinked circles show 
genotypes which differ from nearest linked genotype by more than a SLV. Hand-drawn blue lines 
delineate user-defined sub-clusters based on founder groups A (sub-cluster 1) and B (sub-cluster 
2). The circle colour coding shows ompA genotypes as follows: green = D (subtype D/UW-3CX); 
red = D (subtype D/IC-Cal8); lavender = E; yellow = F; blue = G; light brown = I; purple = J; pink = 
L2; dark brown = L2b. 
 
